Latest Insider Transactions at Tricida, Inc. (TCDA)
This section provides a real-time view of insider transactions for Tricida, Inc. (TCDA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Tricida, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Tricida, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2021
|
David Hirsch Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,403
+37.29%
|
-
|
|
Jun 08
2021
|
Sandra I Coufal Director |
SELL
Open market or private sale
|
Direct |
5,000
-3.39%
|
$20,000
$4.78 P/Share
|
|
May 25
2021
|
Sandra I Coufal Director |
SELL
Open market or private sale
|
Direct |
5,000
-3.28%
|
$20,000
$4.56 P/Share
|
|
Apr 19
2021
|
Sandra I Coufal Director |
SELL
Open market or private sale
|
Direct |
5,000
-3.17%
|
$20,000
$4.54 P/Share
|
|
Mar 10
2021
|
Sandra I Coufal Director |
SELL
Open market or private sale
|
Direct |
5,000
-3.08%
|
$20,000
$4.79 P/Share
|
|
Feb 24
2021
|
Sandra I Coufal Director |
SELL
Open market or private sale
|
Direct |
100
-0.06%
|
$800
$8.01 P/Share
|
|
Feb 08
2021
|
Gerrit Klaerner President and CEO |
SELL
Open market or private sale
|
Direct |
8,000
-1.57%
|
$56,000
$7.26 P/Share
|
|
Feb 03
2021
|
Sandra I Coufal Director |
SELL
Open market or private sale
|
Direct |
5,000
-2.98%
|
$30,000
$6.91 P/Share
|
|
Jan 26
2021
|
Sandra I Coufal Director |
SELL
Open market or private sale
|
Direct |
5,000
-2.9%
|
$35,000
$7.06 P/Share
|
|
Jan 14
2021
|
Gerrit Klaerner President and CEO |
SELL
Open market or private sale
|
Direct |
1,655
-0.32%
|
$11,585
$7.18 P/Share
|
|
Jan 13
2021
|
Gerrit Klaerner President and CEO |
SELL
Open market or private sale
|
Direct |
15,035
-2.87%
|
$105,245
$7.41 P/Share
|
|
Jan 12
2021
|
Gerrit Klaerner President and CEO |
SELL
Open market or private sale
|
Direct |
9,821
-1.84%
|
$68,747
$7.65 P/Share
|
|
Jan 11
2021
|
Gerrit Klaerner President and CEO |
SELL
Open market or private sale
|
Direct |
21,489
-3.87%
|
$150,423
$7.49 P/Share
|
|
Dec 14
2020
|
Sandra I Coufal Director |
SELL
Open market or private sale
|
Direct |
50,000
-22.46%
|
$350,000
$7.9 P/Share
|
|
Dec 11
2020
|
Robert Mc Kague EVP, General Counsel |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$70,000
$7.62 P/Share
|
|
Dec 10
2020
|
Geoffrey M. Parker COO, CFO and EVP |
BUY
Open market or private purchase
|
Indirect |
15,000
+27.27%
|
$90,000
$6.78 P/Share
|
|
Dec 11
2019
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
1,500,000
-13.5%
|
$60,000,000
$40.0 P/Share
|
|
Apr 03
2019
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
225,000
+1.98%
|
$8,100,000
$36.0 P/Share
|
|
Jul 02
2018
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
368,421
+3.27%
|
$6,999,999
$19.0 P/Share
|
|
Jul 02
2018
|
Orbimed Advisors LLC Director |
BUY
Conversion of derivative security
|
Indirect |
10,520,859
+32.27%
|
-
|